[1] Li F,Kong S,Xie K,et al. High ratio of C-reactive protein/procalcitonin predicts Mycoplasma pneumoniae infection among adults hospitalized with community acquired pneumonia[J]. Scand J Clin Lab Invest,2021,81(1):65-71. [2] Song Y,Sun W,Dai D,et al. Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia[J]. Expert Rev Respir Med, 2021,15(5):689-696. [3] 钟明媚,徐康,丁震,等. 中性粒细胞/淋巴细胞比值与CURB-65评分在老年社区获得性肺炎预后评价中的作用[J].中华急诊医学杂志,2021,30(10):1235-1239. [4] 代宝春,徐俊利,王雅坤,等. 维生素D2注射液联合抗生素对社区获得性肺炎患儿炎性因子和免疫功能的影响[J].河北医药,2022,44(7):1018-1021. [5] 卢霞,徐志刚,金晓燕,等. 社区获得性支原体肺炎患儿血清免疫球蛋白白细胞介素-6可溶性白细胞介素-6受体及血沉的变化与病情的关系[J].中国妇幼保健,2022,37(16):3006-3009. [6] Bayramova SS, Nikolayev KY, Tsygankova OV. The use of a new semi-quantitative rapid test for procalcitonin in the diagnosis of multisegmental community-acquired pneumonia[J]. Ter Arkh, 2021,93(3):279-282. [7] Ito A, Ishida T, Tachibana H, et al. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia[J]. Clin Chem Lab Med, 2019,57(10):1632-1637. [8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 成人社区获得性肺炎基层诊疗指南(2018年)[J].中华全科医师杂志,2019,18(2):117-126. [9] Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study[J]. Thorax, 2003,58(5):377-382. [10] 袁晓雨,张铁栓. 平均血小板体积与血小板计数比值在社区获得性肺炎预后中的预测价值[J].中国医药导报,2021,18(28):108-112. [11] 陈金妮, 陈思齐, 冯乃超, 等. 海南地区5岁以下儿童重症社区获得性肺炎病原学分析[J].实用预防医学,2023,30(2):173-177. [12] Dinh A,Ropers J,Duran C,et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards(PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial[J]. Lancet, 2021,397(10280):1195-1203. [13] Du S,Wu X,Li B,et al. Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia[J]. Front Med, 2022,16(3):389-402. [14] 张望,伍勇. 肺泡灌洗液中白细胞分类计数和白介素6检测对社区获得性肺炎的诊断价值[J].实用预防医学,2019,26(10):1271-1273. [15] 来静,王信,田慧娟. 老年社区获得性肺炎患者血小板及血清白介素-6水平检测的临床意义[J].血栓与止血学,2021,27(6):970-971. [16] 张璐,王秀丽,胡婀娜. 加味清气化痰丸治疗社区获得性肺炎的疗效观察以及对血清IL-6、TNF-α水平的影响[J].中国中医药科技,2021,28(2):177-179. [17] 陈晖,王胜昱,刘松,等. 血清和支气管肺泡灌洗液IL-6、IL-8与老年社区获得性肺炎患者预后的相关性研究[J].国际呼吸杂志,2021,41(24):1848-1853. [18] 戈艳蕾,李立群,王红阳,等. 老年重症社区获得性肺炎入住ICU患者血清B型钠尿肽、降钙素原、C反应蛋白水平及临床意义[J].中国老年学杂志,2018,38(10):2384-2385. [19] Schuetz P. Procalcitonin is useful for evaluating patients with ambiguous presentation and for early discontinuation ofantibiotics in community-acquired pneumonia[J]. Am J Respir Crit Care Med, 2020,201(6):744-745. [20] 郭亚威,王萌,朱丹丹,等. 降钙素原联合CURB-65评分对老年社区获得性肺炎患者预后的评估价值[J].中国综合临床,2019,35(1):73-76.
2024, Vol. 31 
